Pages that link to "Q41926678"

The following pages link to Chloroquine inhibits proinflammatory cytokine release into human whole blood. (Q41926678):

Displaying 36 items.

• Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases (Q27010345) (← links)
• Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity (Q28066142) (← links)
• Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis (Q28533957) (← links)
• Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. (Q30540705) (← links)
• Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort (Q30655475) (← links)
• Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort (Q33455990) (← links)
• Effects of chloroquine on viral infections: an old drug against today's diseases? (Q33973620) (← links)
• New concepts in antimalarial use and mode of action in dermatology (Q34007922) (← links)
• Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial (Q34446781) (← links)
• The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release (Q34721762) (← links)
• Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs (Q34896724) (← links)
• Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis (Q35202866) (← links)
• Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys (Q35324935) (← links)
• Treatment of Plasmodium chabaudi Parasites with Curcumin in Combination with Antimalarial Drugs: Drug Interactions and Implications on the Ubiquitin/Proteasome System (Q36830110) (← links)
• Immune quiescence: a model of protection against HIV infection (Q37418185) (← links)
• Toll-like receptor 4 modulation as a strategy to treat sepsis (Q37731959) (← links)
• IL-10 and TNFalpha genotypes in SLE. (Q37772082) (← links)
• The role of antimalarial agents in the treatment of SLE and lupus nephritis (Q37947108) (← links)
• Treatment of severe lupus nephritis: the new horizon. (Q38271125) (← links)
• Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy? (Q38311906) (← links)
• Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases (Q38561490) (← links)
• Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo (Q39155625) (← links)
• Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms (Q40576695) (← links)
• Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. (Q41764934) (← links)
• Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome (Q41915133) (← links)
• Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent (Q41928923) (← links)
• In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes (Q41942150) (← links)
• Are respiratory complications of Plasmodium vivax malaria an underestimated problem? (Q47144740) (← links)
• A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease. (Q50159977) (← links)
• Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy (Q51083193) (← links)
• Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux (Q59809188) (← links)
• CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine (Q89848603) (← links)
• Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides (Q89911986) (← links)
• Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues (Q92026856) (← links)
• Malaria infection promotes a selective expression of kinin receptors in murine liver (Q92994084) (← links)
• Chloroquine and hydroxychloroquine in the context of COVID-19 (Q94561886) (← links)